Houston-based Liongard has fresh funds thanks to a $4.5 million round. Getty Images

A Houston startup has something to roar about. Information Technology automation and management company, Liongard, has closed its latest round of funding at $4.5 million.

The Series A round was lead by TDF Ventures, a software, infrastructure and services fund that has a presence in Washington D.C. and Silicon Valley. Currently, the fund is investing from its $150M Fund IV. Other Liongard investors include ‎Integr8d Capital, Gestalt Theory Venture Partners, Richard Yoo (the Founder of Rackspace Managed Hosting), and others.

The fresh funds will allow for the company to ramp up the development of its Roar platform — a software product that creates a single dashboard for all data systems including the Cloud and apps, server networks, and on-site systems to make accessing and protecting the data easier. The funds will also go toward improving and expanding account management capabilities.

"This investment will help us accelerate development and integrations to create additional visibility across the varied technology stacks that MSPs [or, managed service provider] support," says Joe Alapat, CEO of Liongard, in a release. "Our true goal is to support MSPs across the entire client journey — automating onboarding, documentation, and insight that speeds up issue resolution — unleashing teams to operate at 10X."

The SaaS company has grown its clientbase since its 2015 launch. In spring of 2018, Liongard closed its Seed Stage round of its capital campaign at $1.3 million in investments. With these initial funds, Liongard was able to put Roar on the market in April 2018 and expand its client base — growing from two clients to now close to 200 customers in less than a year.

"Liongard is in a strategic and unique position to disrupt the way MSPs operate and manage IT for their clients," says Jim Pastoriza, managing partner of TDF Ventures, in a release. "We're looking forward to a partnership with a great team building a product that will revolutionize the MSP industry."

Alapat, who runs his company out of Station Houston, told InnovationMap in March that he had a goal for the round to raise between $3 million and $4 million, and said he thinks the company has been received well by Houston investors because Liongard offers a product that other IT management companies don't.

"No one has a unified way to look across the Cloud and network and apps and services and servers," Alapat

says. "There's plenty of different dashboards and solutions that looks at one or two of those things, but there's no single solution that consolidates all of that. That's what makes us different — that we unify all of that under one umbrella."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”